Processing your payment...
Please do not close your browser.

Intra Aortic Counterpulsation Device Market - Global Growth, Trends and Forecast (2022 - 2029) By Types, By Application, By Regions and By Key Players: Teleflex Incorporated (NYSE: TFX), ABIOMED (NASDAQ: ABMD)

24 Jun, 2022 | 158 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Intra-Aortic Counterpulsation Device Market size is projected to accrue voluminously by 2029 registering a phenomenal CAGR of 2.9% during the review period (2022 to 2029).

Intra Aortic Counterpulsation Device Market Overview

The intra-aortic balloon pump is a medical device that aids the heart in pumping more blood to the body parts when it is unable to do so. & The pump is made up of a thin, flexible tube known as a catheter. The balloon is hooked to one end of the catheter, while the other end is connected to a computer console. When the heart beats, this console features a mechanism that inflates and deflates the balloon at the appropriate times. The rising prevalence of cardiac defects, the ageing population, and a variety of technological breakthroughs and improvements in these pumps are all contributing to the global market's growth over the forecast period.

Due to factors such as increased frequency of cardiac abnormalities, growing geriatric population, and a number of technological advances and improvements in these pumps, the intra-aortic balloon pumps market is likely to rise significantly over the forecast period. The expensive cost of an intra-aortic balloon pump, on the other hand, is one of the primary reasons that is anticipated to limit the market's growth.

What is our Intra Aortic Counterpulsation Device Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029 CAGR

 

CAGR of 2.9% during the review period (2022 to 2029).

 

By Type

  • Fiber Optic Type

  • Ordinary Type

 

By Application

  • Hospitals

  • Cardiac Care Centers

  • Other

 

 By Companies

 

 

 

 

Maquet (Getinge Group), Teleflex Incorporated, ABIOMED, Boston Scientific Corporation, Getinge AB., ZEON CORPORATION, MERA, Abiomed

 

 

Regions Covered

 

  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America

 

Base Year

 

 

2022

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

158

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Who are the Major Players in Intra Aortic Counterpulsation Device Market?

The Intra Aortic Counterpulsation Device Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market Maquet (Getinge Group), Teleflex Incorporated (NYSE: TFX), ABIOMED (NASDAQ: ABMD), Boston Scientific Corporation (NYSE: BSX), Getinge AB (STO: GETI-B)., ZEON CORPORATION, Abiomed MERA and others.

Industry News:

April 15, 2021: Abiomed announced that the first patient has been enrolled in PROTECT IV, a large, prospective, multi-center randomized controlled trial (RCT) that is designed to provide the level of clinical evidence needed to achieve a Class I guideline recommendation for Impella in high-risk percutaneous coronary intervention (HRPCI). The first patient was enrolled at Ascension St. John Hospital in Detroit by Ted Schreiber, M.D., chief of cardiology at Ascension St. John Macomb-Oakland Hospital and Amir Kaki, M.D., interventional cardiologist and director of mechanical circulatory support at Ascension St. John Hospital.

May 2, 2017 Teleflex Incorporated (NYSE: TFX), a foremost global provider of medical technologies for critical care and surgery, has announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AC3 OptimusTM Intra-Aortic Balloon Pump (IABP).

June 1, 2020: Boston Scientific (NYSE: BSX) announced the U.S. launch of the DIRECTSENSE™ Technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures. The DIRECTSENSE Technology, which was approved by the US Food and Drug Administration in April and is available on the RHYTHMIA HDxTM

What are the major Applications, Types and Regions for Intra Aortic Counterpulsation Device Market?

By Type, it is segmented into

  • Fiber Optic Type
  • Ordinary Type

By Applications it is segmented into

  • Hospitals
  • Cardiac Care Center
  • Other

Intra Aortic Counterpulsation Device Market Regional Analysis

The intra-aortic balloon pump market is expected to be led by North America. The increase can be attributed to causes such as the rising prevalence of cardiac abnormalities, the widespread acceptance of technologically improved devices, and the product's competitive pricing in the region. The European market is the second most important market. The expanding senior population and frequent product launches by prominent businesses are the main drivers of this region's growth. Asia Pacific is predicted to grow at the fastest rate, with the greatest CAGR. The market in this region is expected to expand due to an increase in the number of patients with heart problems and more patient awareness.

Due to unmet healthcare needs and poor population knowledge, the market in Latin America, the Middle East, and Africa is expected to grow more slowly.

The market for Intra-Aortic Counter Pulsation Device in Asia is predicted to increase rapidly over the next few years, followed by Europe. In Asia, China and India are likely to be the fastest expanding markets.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America

The Intra Aortic Counterpulsation Device Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Intra Aortic Counterpulsation Device Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
  4. Key Insights
    1. Pricing Analysis, By Key Regions, 2022
    2. Price Comparison (USD Per Ton) By Type (Fiber Optic Type, Ordinary Type) 2021/2022
    3. Price Comparison (USD, Per Ton): By Application (Hospitals, Cardiac Care Centers, Other) 2021/2022
    4. Impact of COVID-19 on the Intra Aortic Counterpulsation Device Market
    5. Production Share of Intra Aortic Counterpulsation Device, By Region, 2022
    6. Key Industry Developments
  5. Global Intra Aortic Counterpulsation Device Market Analysis, Insights and Forecast, 2022-2029
    1. Market Analysis, Insights and Forecast – By Application
      1. Hospitals
      2. Cardiac Care Centers
      3. Other
    2. Market Analysis, Insights and Forecast – By Type
      1. Fiber Optic Type
      2. Ordinary Type
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Teleflex Incorporated (NYSE: TFX)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. ABIOMED (NASDAQ: ABMD)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Boston Scientific Corporation (NYSE: BSX)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Getinge AB (STO: GETI-B)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla